The FDA has issued a final guidance on the development, review, and approval or clearance of companion diagnostics and is intending to publish a proposed risk-based oversight framework for laboratory developed tests (LDTs).
CareFusion announced the launch of its ChloraPrep 1mL applicator, the latest addition to the ChloraPrep line.
With the WHO reporting that the death toll in the West African Ebola outbreak has risen to 729, the CDC issued a travel warning for the region
By 2010, one in every 10 visits Americans made to their doctor's office involved diabetes, with the greatest rise among those aged 25-44.
Decision aids are underutilized for advanced care planning and their effectiveness is not well documented, according to a new review.
The FDA has approved Striverdi Respimat (olodaterol; Boehringer Ingelheim) inhalation spray for the treatment of patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema with airflow obstruction.